advertisement
Wu Y 24
Showing records 1 to 24 | Display all abstracts from Wu Y105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Wang N
International immunopharmacology 2022; 112: 109242
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Ouyang J
Human Genetics 2023; 142: 103-123
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Chen D
Neural Regeneration Research 2022; 17: 2755-2760
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Sun W
Human Genetics 2023; 142: 103-123
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Peng C
Neural Regeneration Research 2022; 17: 2755-2760
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Yang Y
International immunopharmacology 2022; 112: 109242
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Ding XM
Neural Regeneration Research 2022; 17: 2755-2760
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Liu Y
International immunopharmacology 2022; 112: 109242
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Shen H
Human Genetics 2023; 142: 103-123
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Wu Y
Neural Regeneration Research 2022; 17: 2755-2760
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Liu X
Human Genetics 2023; 142: 103-123
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Huang L
International immunopharmacology 2022; 112: 109242
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Wu Y
Human Genetics 2023; 142: 103-123
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Gu M
International immunopharmacology 2022; 112: 109242
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Zeng CJ
Neural Regeneration Research 2022; 17: 2755-2760
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Jiang H
Human Genetics 2023; 142: 103-123
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Wu Y
International immunopharmacology 2022; 112: 109242
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Xu L
Neural Regeneration Research 2022; 17: 2755-2760
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Xu L
International immunopharmacology 2022; 112: 109242
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Li X
Human Genetics 2023; 142: 103-123
105427 Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia/reperfusion injury
Guo WY
Neural Regeneration Research 2022; 17: 2755-2760
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Wang Y
Human Genetics 2023; 142: 103-123
105856 Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury
Sun H; Guo W
International immunopharmacology 2022; 112: 109242
105821 Truncation mutations in MYRF underlie primary angle closure glaucoma
Jiang Y; Li S; Xiao X; Hejtmancik JF; Tan Z; Zhang Q
Human Genetics 2023; 142: 103-123
